TY  - GEN
AU  - Colombel,J-F
AU  - Sandborn,W J
AU  - Reinisch,W
AU  - Peyrin-Biroulet,L
AU  - Panaccione,R
AU  - Rutgeerts,P
AU  - Hanauer,S B
AU  - Ghosh,S
AU  - Van Assche,G
AU  - Robinson,A M
AU  - Lau,W
AU  - Maa,J-F
AU  - Huang,B
AU  - Pappalardo,B
AU  - Read,H
TI  - Long-term safety of adalimumab in clinical trials in adult patients with Crohn's disease or ulcerative colitis
SN  - 1365-2036
PY  - 2018///0521
KW  - Adalimumab
KW  - administration & dosage
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Clinical Trials as Topic
KW  - statistics & numerical data
KW  - Colitis, Ulcerative
KW  - drug therapy
KW  - Crohn Disease
KW  - Drug-Related Side Effects and Adverse Reactions
KW  - epidemiology
KW  - Female
KW  - Humans
KW  - Long-Term Care
KW  - Male
KW  - Middle Aged
KW  - Opportunistic Infections
KW  - chemically induced
KW  - Time Factors
KW  - Young Adult
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/apt.14420
ER  -